LifeCell forays into skincare market with AreoVeda

LifeCell, a pioneer in stem cell banking and diagnostics, has ventured into the skincare market with the launch of AreoVeda. This revolutionary brand is the first in India to focus on skincare for pregnant women, new mothers, and newborns, setting a new benchmark for safety and efficacy through its unique cellular testing approach.
AreoVeda's product range addresses common skin concerns such as stretch marks, pigmentation, acne, and dryness in expectant and new mothers, as well as eczema, diaper rash, and cradle cap in babies. Each product undergoes rigorous testing on lab-grown human skin cells to ensure safety and effectiveness.
A standout feature of AreoVeda is its commitment to purity and sustainability. The brand has secured both EWG and ECOCERT COSMOS certifications, a rare achievement signifying the use of natural, safe ingredients. AreoVeda also employs a unique cryomilling process to preserve the potency of key ingredients.
"We are thrilled to introduce AreoVeda, a brand that combines nature's goodness with cutting-edge science," said Taru Mayur, Co-founder of AreoVeda. "Our commitment to safety and efficacy is unparalleled, and we believe AreoVeda will become a trusted companion for mothers and babies during this special phase of life."
AreoVeda's product line includes a range of creams, serums, washes, and lotions for pregnant women, new mothers, and newborns. The products are available for purchase on the AreoVeda website and major e-commerce platforms.